• HOME
  • NEWS
    • BIOENGINEERING
    • SCIENCE NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • FORUM
    • INSTAGRAM
    • TWITTER
  • CONTACT US
Saturday, April 10, 2021
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
    • BIOENGINEERING
    • SCIENCE NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • FORUM
    • INSTAGRAM
    • TWITTER
  • CONTACT US
  • HOME
  • NEWS
    • BIOENGINEERING
    • SCIENCE NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • FORUM
    • INSTAGRAM
    • TWITTER
  • CONTACT US
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News

Three brain chemicals affect how we handle uncertainty

Bioengineer by Bioengineer
November 15, 2016
in Science News
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram
IMAGE

Credit: Edvard Munch and Roland Roberts

New research has revealed how three important brain signaling chemicals affect the way that we handle uncertainty. It turns out that noradrenaline regulates our estimates of how unstable the environment is, acetylcholine helps us adapt to changing environments, and dopamine pushes us to act on our beliefs about uncertainty. The research, publishing 15 November in the open-access journal PLOS Biology, was led by Louise Marshall and Dr Sven Bestmann at the UCL (University College London) Institute of Neurology.

The study involved 128 healthy participants who took part in a reaction-time task designed to test how they handled uncertainty. Participants were all given either a placebo or a drug to block noradrenaline, acetylcholine or dopamine before starting the task. Participants responded to symbols that were presented one after the other by pressing a corresponding button. The probability of each symbol appearing was dependent on the symbol that appeared previously; for example, if a participant had just seen symbol A, there was an 85% chance that symbol B would appear next. Every 50 trials, these probability patterns changed without warning, so participants had to detect these new patterns and adjust their responses accordingly.

Lead author Louise Marshall said: "Interacting with our dynamic and ever-changing environment requires us to frequently update our beliefs about the world. By learning the relationships that link events occurring in our environment, we can predict future events, and execute fast, accurate responses. However, the environment's complex dynamics give rise to uncertainty about the relationships between events, and uncertainty about the stability of these relationships over time. Several brain chemicals have been proposed to modulate how we handle uncertainty. Here we combined pharmacological interventions and novel computational models to determine how noradrenaline, acetylcholine and dopamine enable our brains to learn the changing relationships in our environment. The results shed important light on how humans learn to behave under uncertainty."

###

In your coverage please use this URL to provide access to the freely available article in PLOS Biology: http://journals.plos.org/plosbiology/article?id=10.1371/journal.pbio.1002575

Citation: Marshall L, Mathys C, Ruge D, de Berker AO, Dayan P, Stephan KE, et al. (2016) Pharmacological Fingerprints of Contextual Uncertainty. PLoS Biol 14(11): e1002575. doi:10.1371/journal.pbio.1002575

Funding: This work was supported by the Medical Research Council (LM and AOdB), the European Research Council, grant number ActSelectContext 260424 (SB), the Gatsby Charitable Foundation (PD), the Clinical Research Priority Program "Molecular Imaging" (KES), the René and Susanne Braginsky Foundation (KES), the Tourette Syndrome Association (DR), a Dorothy Feiss Scientific Research Grant (DR), and core funding from the Wellcome Trust Centre for Neuroimaging (CM) and the University of Zurich (KES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Competing Interests: The authors have declared that no competing interests exist.

Media Contact

Louise Marshall
[email protected]

http://www.plos.org

############

Story Source: Materials provided by Scienmag

Share12Tweet7Share2ShareShareShare1

Related Posts

IMAGE

Men with low health literacy less likely to choose active surveillance for prostate cancer after tumor profiling

April 10, 2021
IMAGE

Level of chromosomal abnormality in lung cancer may predict immunotherapy response

April 10, 2021

Mutant KRAS and p53 cooperate to drive pancreatic cancer metastasis

April 10, 2021

Better metric for thermoelectric materials means better design strategies

April 10, 2021

Leave a Reply Cancel reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

POPULAR NEWS

  • IMAGE

    Terahertz accelerates beyond 5G towards 6G

    851 shares
    Share 340 Tweet 213
  • Jonathan Wall receives $1.79 million to develop new amyloidosis treatment

    59 shares
    Share 24 Tweet 15
  • UofL, Medtronic to develop epidural stimulation algorithms for spinal cord injury

    55 shares
    Share 22 Tweet 14
  • A sturdier spike protein explains the faster spread of coronavirus variants

    43 shares
    Share 17 Tweet 11

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Tags

GeneticsCell BiologyBiologyPublic HealthMedicine/HealthcancerInfectious/Emerging DiseasesMaterialsTechnology/Engineering/Computer ScienceClimate ChangeChemistry/Physics/Materials SciencesEcology/Environment

Recent Posts

  • Men with low health literacy less likely to choose active surveillance for prostate cancer after tumor profiling
  • Level of chromosomal abnormality in lung cancer may predict immunotherapy response
  • Mutant KRAS and p53 cooperate to drive pancreatic cancer metastasis
  • Better metric for thermoelectric materials means better design strategies
  • Contact Us

© 2019 Bioengineer.org - Biotechnology news by Science Magazine - Scienmag.

No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

© 2019 Bioengineer.org - Biotechnology news by Science Magazine - Scienmag.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In